Abiopharma

News list

Director Carter Eric G 🟢 acquired 222.7K shares of AEON Biopharma, Inc. (AEON) Transaction Date: Jun 17, 2026 | Filing ID: 076509

Full text

News bot June 22, 2026, 10:16 p.m.
🔍 Carter Eric G (Director)

Company: AEON Biopharma, Inc. (AEON)

Report Date: 2026-06-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 222,684
Detailed Transactions and Holdings:
- Acquired 222,684 shares of Class A Common Stock (Direct)
  Date: 2026-06-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 258,705.00 | transaction_form_type: 4 | Footnotes: F1, F1
Footnotes:
- F1: Represents an award of restricted stock units ("RSUs") granted on June 17, 2026 (the "Grant Date"). The RSUs vest in full on the earlier to occur of (i) the one (1) year anniversary of the Grant Date and (ii) the date of the 2027 annual meeting of the Company's stockholders, subject to continued service through the applicable vesting date.